Zurko Research, the company that accumulates more than 16 years of experience in the evaluation of cosmetic and sanitary products, has purchased 70% of the actions of the company of the group Proteos Biotech SL.
To his time, this operation serves to allow the entrance in 30% of remaining shareholders to Group Tresmares Capital, platform of investment leader in Spain that has the backrest of the Bank Santander.
Zurko Research Is a testimony of the commitment of Zurko to support and do grow business projects based in the quality, the security and the excellence. The company already purchased in the month of March the Centre of Technology Capilar, and the General Director of the Group Zurko Research explained that this type of operations help to perfect knowledge in determinate areas of knowledge, in addition to following keeping his independence regarding investments.
From the own company ensure that they face this new stage with illusion and with the convencimiento to follow exploring opportunities of growth and desarollo economic.